Drug
MRG-001
MRG-001 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
4
80%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(1)
Other(2)
Detailed Status
Not yet recruiting2
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 24 (80.0%)
Trials by Status
completed120%
not_yet_recruiting240%
unknown240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients
NCT05844527
not_yet_recruitingphase_2
MRG-001 in Patients With Amyotrophic Lateral Sclerosis
NCT06315608
not_yet_recruitingphase_2
MRG-001 in Patients With Alcoholic Hepatitis
NCT06307522
unknownphase_1
Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)
NCT05155839
unknownphase_2
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
NCT04646603
Clinical Trials (5)
Showing 5 of 5 trials
NCT05844527Phase 2
Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients
NCT06315608Phase 2
MRG-001 in Patients With Amyotrophic Lateral Sclerosis
NCT06307522Phase 2
MRG-001 in Patients With Alcoholic Hepatitis
NCT05155839Phase 1
Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)
NCT04646603Phase 2
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5